Raymond Stein MD presented his outcomes of Corneal Cross-linking at the American Academy of Ophthalmology (AAO) in Chicago on Oct 19, 2010.
The AAO is the largest ophthalmological meeting in the world with an attendance of over 20,000.
Dr Raymond Stein in Toronto is considered one of the most experienced with Corneal Collagen Cross-Linking in North America having treated over 1,500 eyes with keratoconus.
Read more about Dr Raymond Stein and what his patients are saying.
“Laser vision correction has been an exciting and innovative area of clinical practice. I feel fortunate to have been involved in Excimer laser treatments over the past 20 years. I have used Excimer lasers that were the size of a small bus. I performed treatments that took as long as a full song by the Beatles. I saw patients in the early laser days who if they had to rate their post-op pain on a scale of 1-10 with 10 being the highest, they rated it an 11. Despite this level of discomfort, they all came back for their second eye.” from EyeWorld
Raymond Stein learn more
Raymond Stein MD- As featured in ASCRS EyeWorld Publication
Click here to Read More:
Click on the Thumbnails to view the inside of Raymond Stein’s Thank you Cards!
Thank you very much Ray Stein!
Please Click on thumbnail to view the inside of the Card
Click on the image to view the patient testimonial
Raymond Stein MD Toronto- Patient Thank you Cards
Thank You Raymond Stein
Raymond Stein MD- Patient's express their Thank You's!
Learn more about Raymond Stein Toronto
Read more about Raymond Stein
Dr Raymond Stein, a cornea and refractive surgery specialist, was elected to the Board of Directors of the Foundation Fighting Blindness (FFB). The FFB is one of the most established eye charities in Canada founded in 1974 and devoted to funding research into degenerative retinal disorders. Over the past 8 years Dr Raymond Stein and the Bochner Eye Institute have been active in supporting ComicVision, an annual event organized by the FFB, that is held in major cities across Canada. Dr. Raymond Stein is encouraged by the research funded by FFB which has shown major advances in establishing potential cures for vision threatening retinal disorders such as retinitis pigmentosa.
